358 related articles for article (PubMed ID: 33766750)
1. Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Ashrafizaveh S; Ashrafizadeh M; Zarrabi A; Husmandi K; Zabolian A; Shahinozzaman M; Aref AR; Hamblin MR; Nabavi N; Crea F; Wang Y; Ahn KS
Cancer Lett; 2021 Jun; 508():104-114. PubMed ID: 33766750
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells.
Khalili-Tanha G; Moghbeli M
Cell Mol Biol Lett; 2021 Aug; 26(1):39. PubMed ID: 34425750
[TBL] [Abstract][Full Text] [Related]
3. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.
Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM
Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy.
Cai Q; Wang S; Jin L; Weng M; Zhou D; Wang J; Tang Z; Quan Z
Mol Cancer; 2019 Apr; 18(1):82. PubMed ID: 30953511
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
6. The role of miRNAs and lncRNAs in conferring resistance to doxorubicin.
Taheri M; Mahmud Hussen B; Tondro Anamag F; Shoorei H; Dinger ME; Ghafouri-Fard S
J Drug Target; 2022 Jan; 30(1):1-21. PubMed ID: 33788650
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
8. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells.
Liu Q; Sun S; Yu W; Jiang J; Zhuo F; Qiu G; Xu S; Jiang X
J Neurooncol; 2015 Apr; 122(2):283-92. PubMed ID: 25645334
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer.
Peng Y; Tang D; Zhao M; Kajiyama H; Kikkawa F; Kondo Y
Cancer Metastasis Rev; 2020 Sep; 39(3):825-835. PubMed ID: 32594276
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
Zhu KP; Zhang CL
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
[No Abstract] [Full Text] [Related]
12. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
Jin KT; Lu ZB; Lv JQ; Zhang JG
RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
Yang Y; Dai W; Sun Y; Zhao Z
Oncol Rep; 2019 Apr; 41(4):2311-2320. PubMed ID: 30720129
[TBL] [Abstract][Full Text] [Related]
14. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.
Torki Z; Ghavi D; Hashemi S; Rahmati Y; Rahmanpour D; Pornour M; Alivand MR
Cancer Chemother Pharmacol; 2021 Nov; 88(5):771-793. PubMed ID: 34510251
[TBL] [Abstract][Full Text] [Related]
15. miRNAs as short non-coding RNAs in regulating doxorubicin resistance.
Mirzaei S; Paskeh MDA; Moghadam FA; Entezari M; Koohpar ZK; Hejazi ES; Rezaei S; Kakavand A; Aboutalebi M; Zandieh MA; Rajabi R; Salimimoghadam S; Taheriazam A; Hashemi M; Samarghandian S
J Cell Commun Signal; 2023 Dec; 17(4):1181-1202. PubMed ID: 38019354
[TBL] [Abstract][Full Text] [Related]
16. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
17. Autophagy and doxorubicin resistance in cancer.
Chen C; Lu L; Yan S; Yi H; Yao H; Wu D; He G; Tao X; Deng X
Anticancer Drugs; 2018 Jan; 29(1):1-9. PubMed ID: 29099416
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
Zhang H; Guo Y; Song Y; Shang C
Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs in cancer drug resistance development.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
